Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin

Ophthalmology

Volumn 112, Issue 11, 2005, Pages 1896-1903

  Van De Moere, Ann ^a   Sandhu, Sukhpal S ^a   Kak, Rajeev ^a   Mitchell, Keith W ^a   Talks, Stephen J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL SIGNIFICANCE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; ADJUVANT CHEMOTHERAPY; CONNECTIVE TISSUE; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; INJECTION; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; RETINA MACULA DEGENERATION; SCLERA;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CHOROIDAL NEOVASCULARIZATION; CONNECTIVE TISSUE; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SCLERA; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 27644527756     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.06.018     Document Type: Article

References (26)

1. P. Mitchell, W. Smith, K. Attebo, J.J. Wang Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study Ophthalmology 102 1995 1450 1460
2. R. Klein, B.E. Klein, K.L. Linton Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 99 1992 933 943
3. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of 2 randomized clinical trials-TAP report Arch Ophthalmol 117 1999 1329 1345
4. J.G. Arroyo, N. Michaud, F.A. Jakobiec Choroidal neovascular membranes treated with photodynamic therapy Arch Ophthalmol 121 2003 898 903
5. S. Grisanti, O. Tatar, S. Canbek Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy Am J Ophthalmol 137 2004 914 923
6. U. Schmidt-Erfurth, S. Michels, I. Barbazetto, H. Laqua Photodynamic effects on choroidal neovascularization and physiological choroid Invest Ophthalmol Vis Sci 43 2002 830 841
7. U. Schmidt-Erfurth, U. Schlotzer-Schrehard, C. Cursiefen Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Invest Ophthalmol Vis Sci 44 2003 4473 4480
8. A.N. Antoszyk, J.L. Gottlieb, R. Machemer, D.L. Hatchell The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization Graefes Arch Clin Exp Ophthalmol 231 1993 34 40
9. T.A. Ciulla, M.H. Criswell, R.P. Danis, T.E. Hill Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model Arch Ophthalmol 119 2001 399 404
10. T. Ishibashi, K. Miki, N. Sorgente Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate Arch Ophthalmol 103 1985 708 711
11. P.L. Penfold, L. Wen, M.C. Madigan Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line implications for macular degeneration Clin Exp Immunol 121 2000 458 465
12. E. Rechtman, R.P. Danis, L.M. Pratt, A. Harris Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age related macular degeneration Br J Ophthalmol 88 2004 344 347
13. R.F. Spaide, J. Sorenson, L. Maranan Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization Ophthalmology 110 2003 1517 1525
14. R.F. Spaide, J. Sorenson, L. Maranan Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization Ophthalmology 112 2005 301 304
15. R.P. Danis, T.A. Ciulla, L.M. Pratt, W. Anliker Intravitreal triamcinolone acetonide in exudative age-related macular degeneration Retina 20 2000 244 250
16. M.C. Gillies, J.M. Simpson, F.A. Billson Safety of an intravitreal injection of triamcinolone results from a randomized clinical trial Arch Ophthalmol 122 2004 336 340
17. J.B. Jonas, I. Kreissig, P. Hugger Intravitreal triamcinolone acetonide for exudative age related macular degeneration Br J Ophthalmol 87 2003 462 468
18. C.J. Helm, G.N. Holland The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis Am J Ophthalmol 120 1995 55 64
19. A.J. Mueller, G. Jian, A.S. Banker The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure Am J Ophthalmol 125 1998 158 163
20. V. Tanner, J.J. Kanski, P.A. Frith Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis Eye 12 1998 679 685
21. Macular Photocoagulation Study Group Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study Arch Ophthalmol 109 1991 1242 1257
22. M.P. Blair, R.S. Apte, P.H. Miskala Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin Retina 24 2004 501 506
23. E. Ergun, N. Maar, W. Radner Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration Ophthalmology 110 2003 65 69
24. U.M. Schmidt-Erfurth, H. Elsner, N. Terai Effects of verteporfin therapy on central visual field function Ophthalmology 111 2004 931 939
25. M.C. Gillies, J.M. Simpson, W. Luo A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration one-year results Arch Ophthalmol 121 2003 667 673
26. J.B. Jonas, I. Kreissig, R. Degenring Intraocular pressure after intravitreal injection of triamcinolone acetonide Br J Ophthalmol 87 2003 24 27